Class I restricted cytotoxic T-lymphocyte (CTL) responses are thought to be
focused against few immunodominant epitopes. In humans, an often quoted ex
ample of such narrow focus is the influenza A (FLU) matrix 58-66 specific m
emory CTL activity, detectable in HLA-AZ individuals as a result of natural
infection. Herein, we analyzed the repertoire of memory, FLU-specific CTLs
in A2 and A11 positive individuals. Eighteen A2.1 binding peptides, derive
d from the FLU-Puerto Rico/8/34 (PR8) isolate, elicited CTL activity in A2.
1/Kb transgenic mice upon direct immunization. These peptides were also tes
ted for their capacity to recall memory CTL responses From peripheral blood
mononuclear cells (PBMC) of human A2.1 donors. Besides the known dominant
M1.58 peptide, 5 new epitopes (PA.46, PA.225, PB1.413, NA.75 and M1.59) wer
e identified. Similarly, eleven, All-binding, FLU-PR8 peptides, which were
immunogenic in HLA-A11/Kb transgenic mice, were assayed fur induction of re
call CTL responses using peripheral blood lymphocytes from a cohort of All-
positive donors. Fight different peptides (NP.188, NP.342, HA.63 HA.149 HA.
450, M1.13, M1.178, and M2.70) induced memory CTL activity. Several of thes
e peptides were found to be highly conserved amongst: different FLU isolate
s, and also capable of binding multiple A3 and A11 supertype molecules. Fin
ally, 37 HLA-B7 binding peptides were also identified. In conclusion, a pre
viously unappreciated breadth of FLU-specific, memory CTL responses in huma
ns was revealed. The relevance of these findings to the design of multiepit
ope vaccines is discussed. Human Immunology 61, 438-452 (2000). (C) America
n Society for Histocompatibility and Immunogenetics, 2000. Published by Els
evier Science Inc.